• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变型亨廷顿蛋白片段在体外和体内以多聚谷氨酰胺长度依赖性方式形成寡聚物。

Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo.

机构信息

Gladstone Institute of Neurological Disease, University of California, San Francisco, California 94158, USA.

出版信息

J Biol Chem. 2010 May 7;285(19):14777-90. doi: 10.1074/jbc.M109.093708. Epub 2010 Mar 10.

DOI:10.1074/jbc.M109.093708
PMID:20220138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2863238/
Abstract

Huntington disease (HD) is caused by an expansion of more than 35-40 polyglutamine (polyQ) repeats in the huntingtin (htt) protein, resulting in accumulation of inclusion bodies containing fibrillar deposits of mutant htt fragments. Intriguingly, polyQ length is directly proportional to the propensity for htt to form fibrils and the severity of HD and is inversely correlated with age of onset. Although the structural basis for htt toxicity is unclear, the formation, abundance, and/or persistence of toxic conformers mediating neuronal dysfunction and degeneration in HD must also depend on polyQ length. Here we used atomic force microscopy to demonstrate mutant htt fragments and synthetic polyQ peptides form oligomers in a polyQ length-dependent manner. By time-lapse atomic force microscopy, oligomers form before fibrils, are transient in nature, and are occasionally direct precursors to fibrils. However, the vast majority of fibrils appear to form by monomer addition coinciding with the disappearance of oligomers. Thus, oligomers must undergo a major structural transition preceding fibril formation. In an immortalized striatal cell line and in brain homogenates from a mouse model of HD, a mutant htt fragment formed oligomers in a polyQ length-dependent manner that were similar in size to those formed in vitro, although these structures accumulated over time in vivo. Finally, using immunoelectron microscopy, we detected oligomeric-like structures in human HD brains. These results demonstrate that oligomer formation by a mutant htt fragment is strongly polyQ length-dependent in vitro and in vivo, consistent with a causative role for these structures, or subsets of these structures, in HD pathogenesis.

摘要

亨廷顿病(HD)是由亨廷顿蛋白(htt)中超过 35-40 个谷氨酰胺(polyQ)重复扩展引起的,导致包含突变 htt 片段纤维状沉积物的包含体的积累。有趣的是,polyQ 长度与 htt 形成纤维的倾向以及 HD 的严重程度成正比,与发病年龄成反比。尽管 htt 毒性的结构基础尚不清楚,但介导 HD 中神经元功能障碍和退化的毒性构象体的形成、丰度和/或持久性也必须依赖于 polyQ 长度。在这里,我们使用原子力显微镜证明突变 htt 片段和合成 polyQ 肽以 polyQ 长度依赖性的方式形成寡聚物。通过延时原子力显微镜,寡聚体在纤维形成之前形成,本质上是瞬态的,并且偶尔是纤维的直接前体。然而,绝大多数纤维似乎通过单体添加形成,与寡聚体的消失同时发生。因此,寡聚体必须在形成纤维之前经历主要的结构转变。在永生化纹状体细胞系和 HD 小鼠模型的脑匀浆中,突变 htt 片段以 polyQ 长度依赖性的方式形成寡聚体,其大小与体外形成的寡聚体相似,尽管这些结构在体内随时间积累。最后,使用免疫电子显微镜,我们在人类 HD 大脑中检测到类似寡聚体的结构。这些结果表明,突变 htt 片段的寡聚体形成在体外和体内强烈依赖于 polyQ 长度,这与这些结构或这些结构的子集在 HD 发病机制中的因果作用一致。

相似文献

1
Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo.突变型亨廷顿蛋白片段在体外和体内以多聚谷氨酰胺长度依赖性方式形成寡聚物。
J Biol Chem. 2010 May 7;285(19):14777-90. doi: 10.1074/jbc.M109.093708. Epub 2010 Mar 10.
2
A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesis.一系列 N 端表位标记的 Hdh 基因敲入等位基因,表达正常和突变 huntingtin:它们在理解增加正常 Huntingtin 的 polyglutamine 延伸长度对 CAG140 小鼠模型发病机制的影响中的应用。
Mol Brain. 2012 Aug 14;5:28. doi: 10.1186/1756-6606-5-28.
3
Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer.突变型亨廷顿蛋白外显子1的折叠态势:可扩散多聚体、寡聚体和原纤维,未检测到单体
PLoS One. 2016 Jun 6;11(6):e0155747. doi: 10.1371/journal.pone.0155747. eCollection 2016.
4
Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.通过表达带有聚谷氨酰胺扩增的截短型和全长亨廷顿蛋白的高容量腺病毒载体,在原代神经元细胞培养物和体内诱导亨廷顿蛋白包涵体形成。
J Gene Med. 2008 Mar;10(3):269-79. doi: 10.1002/jgm.1150.
5
Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice.胶质细胞中的突变亨廷顿蛋白使亨廷顿病小鼠的神经症状恶化。
J Biol Chem. 2010 Apr 2;285(14):10653-61. doi: 10.1074/jbc.M109.083287. Epub 2010 Feb 9.
6
Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment.单克隆抗体识别突变型亨廷顿蛋白片段中由聚谷氨酰胺形成的不同构象表位。
J Biol Chem. 2009 Aug 7;284(32):21647-58. doi: 10.1074/jbc.M109.016923. Epub 2009 Jun 2.
7
Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.突变型亨廷顿蛋白促进野生型亨廷顿蛋白的纤维形成:亨廷顿舞蹈症中亨廷顿蛋白功能丧失的一种潜在机制。
J Biol Chem. 2003 Oct 17;278(42):41452-61. doi: 10.1074/jbc.M303354200. Epub 2003 Jul 29.
8
Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.在亨廷顿舞蹈症的YAC小鼠模型中,全长突变型亨廷顿蛋白对于纹状体神经元Ca2+信号改变和细胞凋亡是必需的。
Neurobiol Dis. 2008 Jul;31(1):80-8. doi: 10.1016/j.nbd.2008.03.010. Epub 2008 Apr 16.
9
Comparison of huntingtin proteolytic fragments in human lymphoblast cell lines and human brain.人类淋巴母细胞系和人脑亨廷顿蛋白水解片段的比较。
J Neurochem. 2002 Jul;82(1):84-92. doi: 10.1046/j.1471-4159.2002.00940.x.
10
Native mutant huntingtin in human brain: evidence for prevalence of full-length monomer.人脑中原位突变 huntingtin:全长单体普遍存在的证据。
J Biol Chem. 2012 Apr 13;287(16):13487-99. doi: 10.1074/jbc.M111.286609. Epub 2012 Feb 27.

引用本文的文献

1
Direct Observation of Secondary Nucleation in Huntingtin Amyloid Formation by High-Speed Atomic Force Microscopy.通过高速原子力显微镜直接观察亨廷顿蛋白淀粉样蛋白形成过程中的二次成核
J Am Chem Soc. 2025 Jun 25;147(25):21973-21984. doi: 10.1021/jacs.5c05571. Epub 2025 Jun 12.
2
Underestimated role of macromolecular crowding in bioengineered models of health and diseases.大分子拥挤效应在生物工程健康与疾病模型中被低估的作用。
Mater Today Bio. 2025 Apr 17;32:101772. doi: 10.1016/j.mtbio.2025.101772. eCollection 2025 Jun.
3
Multimer Detection System: A Universal Assay System for Differentiating Protein Oligomers from Monomers.多聚体检测系统:一种用于区分蛋白质寡聚体和单体的通用检测系统。
Int J Mol Sci. 2025 Jan 30;26(3):1199. doi: 10.3390/ijms26031199.
4
Biochemical analysis to study wild-type and polyglutamine-expanded ATXN3 species.用于研究野生型和多聚谷氨酰胺扩展型ATXN3蛋白的生化分析。
PLoS One. 2024 Dec 23;19(12):e0315868. doi: 10.1371/journal.pone.0315868. eCollection 2024.
5
"Prion-like" seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders.神经退行性疾病中寡聚蛋白聚集体的“类朊病毒”种子形成与传播
Front Neurosci. 2024 Aug 5;18:1436262. doi: 10.3389/fnins.2024.1436262. eCollection 2024.
6
Biomolecular condensates and disease pathogenesis.生物分子凝聚物与疾病发病机制。
Sci China Life Sci. 2024 Sep;67(9):1792-1832. doi: 10.1007/s11427-024-2661-3. Epub 2024 Jul 17.
7
Reviewing the Structure-Function Paradigm in Polyglutamine Disorders: A Synergistic Perspective on Theoretical and Experimental Approaches.综述多聚谷氨酰胺疾病的结构-功能范式:理论和实验方法的协同视角。
Int J Mol Sci. 2024 Jun 20;25(12):6789. doi: 10.3390/ijms25126789.
8
Huntington's Disease: Complex Pathogenesis and Therapeutic Strategies.亨廷顿病:复杂的发病机制与治疗策略。
Int J Mol Sci. 2024 Mar 29;25(7):3845. doi: 10.3390/ijms25073845.
9
Solid-state nuclear magnetic resonance in the structural study of polyglutamine aggregation.固态核磁共振在聚谷氨酰胺聚集结构研究中的应用
Biochem Soc Trans. 2024 Apr 24;52(2):719-731. doi: 10.1042/BST20230731.
10
The polyglutamine domain is the primary driver of seeding in huntingtin aggregation.多聚谷氨酰胺结构域是亨廷顿聚集物中引发聚集的主要驱动因素。
PLoS One. 2024 Mar 14;19(3):e0298323. doi: 10.1371/journal.pone.0298323. eCollection 2024.

本文引用的文献

1
Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease.体内基因疗法可改善亨廷顿舞蹈病多种小鼠模型的运动、认知和神经病理学症状。
J Neurosci. 2009 Oct 28;29(43):13589-602. doi: 10.1523/JNEUROSCI.4286-09.2009.
2
Secondary structure of Huntingtin amino-terminal region.亨廷顿蛋白氨基末端区域的二级结构。
Structure. 2009 Sep 9;17(9):1205-12. doi: 10.1016/j.str.2009.08.002.
3
Polyglutamine dances the conformational cha-cha-cha.多聚谷氨酰胺跳着构象恰恰舞。
Structure. 2009 Sep 9;17(9):1151-3. doi: 10.1016/j.str.2009.08.004.
4
Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment.单克隆抗体识别突变型亨廷顿蛋白片段中由聚谷氨酰胺形成的不同构象表位。
J Biol Chem. 2009 Aug 7;284(32):21647-58. doi: 10.1074/jbc.M109.016923. Epub 2009 Jun 2.
5
Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity.亨廷顿蛋白外显子1的体外和体内淀粉样蛋白的不同构象表现出不同的细胞毒性。
Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9679-84. doi: 10.1073/pnas.0812083106. Epub 2009 Jun 1.
6
Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism.亨廷顿蛋白外显子1 N端的多聚谷氨酰胺破坏引发了一种复杂的聚集机制。
Nat Struct Mol Biol. 2009 Apr;16(4):380-9. doi: 10.1038/nsmb.1570. Epub 2009 Mar 8.
7
Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells.特定大小的突变亨廷顿蛋白N端片段在神经元细胞中介导聚集和毒性。
J Biol Chem. 2009 Apr 17;284(16):10855-67. doi: 10.1074/jbc.M804813200. Epub 2009 Feb 9.
8
Sodium dodecyl sulfate-insoluble oligomers are involved in polyglutamine degeneration.十二烷基硫酸钠不溶性寡聚体参与聚谷氨酰胺变性。
FASEB J. 2008 Sep;22(9):3348-57. doi: 10.1096/fj.07-103887. Epub 2008 Jun 17.
9
Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.灵敏的生化聚集体检测揭示了亨廷顿舞蹈症细胞和小鼠模型中在症状出现之前的聚集起始。
J Neurochem. 2008 Feb;104(3):846-58. doi: 10.1111/j.1471-4159.2007.05032.x. Epub 2007 Nov 6.
10
Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic.在包涵体形成之前形成的可溶性聚谷氨酰胺寡聚体具有细胞毒性。
Hum Mol Genet. 2008 Feb 1;17(3):345-56. doi: 10.1093/hmg/ddm311. Epub 2007 Oct 18.